Ambagon Therapeutics
Laura Demmers is a Senior Scientist at Ambagon Therapeutics since October 2021. Previously, Laura worked as a Scientist at Utrecht University from September 2016 to October 2021, focusing on Chemical Immunology. Laura has also held various research intern positions at prestigious institutes such as the Hubrecht Institute and Radboud Institute for Molecular Life Sciences, where Laura delved into topics such as protein interaction networks and mRNA modifications. Laura holds a Master's Degree in Cancer, Stem Cells and Developmental Biology from Utrecht University and a Bachelor's Degree in Biochemistry and Molecular Biology from Avans University of Applied Sciences.
This person is not in any offices
Ambagon Therapeutics
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.